Özkan S, Gezer D. The impact of dapagliflozin on FIB-4 index over 2 years in patients with type 2 diabetes mellitus. Eur Res J [Internet]. 2025 Jul. 3 [cited 2026 Apr. 5];11(4):676-82. Available from: https://eurj.org.tr/article/view/1061